Literature DB >> 568585

Pharmacokinetics of pancreatic polypeptide in man.

T E Adrian, G R Greenberg, H S Besterman, S R Bloom.   

Abstract

Pure bovine pancreatic polypeptide (PP) was infused into 23 healthy subjects at doses of 1, 3, and 5 pmol/kg/min over 60 minutes and plasma PP was measured by radioimmunoassay. During the infusions mean plasma levels of 203 +/- 34, 575 +/- 73, and 930 +/- 48 pmol/l respectively were achieved. Mean disappearance half time on stopping the infusion was 6.9 +/- 0.3 min (mean +/- SEM). The metabolic clearance rate was 5.1 +/- 0.2 ml/kg/min (mean +/- SEM) and the apparent volume of distribution was calculated to be 51 +/- 3 ml/kg (mean +/- SEM). This study provides for the first time pharmacokinetic data for PP in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568585      PMCID: PMC1412351          DOI: 10.1136/gut.19.10.907

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Isolation and characterization of chicken insulin.

Authors:  J R Kimmel; H G Pollock; R L Hazelwood
Journal:  Endocrinology       Date:  1968-12       Impact factor: 4.736

2.  Regulation in healthy subjects of the secretion of human pancreatic polypeptide, a newly recognized pancreatic islet polypeptide.

Authors:  J C Floyd; S S Fajans; S Pek
Journal:  Trans Assoc Am Physicians       Date:  1976

3.  Distribution and release of human pancreatic polypeptide.

Authors:  T E Adrian; S R Bloom; M G Bryant; J M Polak; P H Heitz; A J Barnes
Journal:  Gut       Date:  1976-12       Impact factor: 23.059

4.  Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy.

Authors:  T W Schwartz; J F Rehfeld; F Stadil; L I Larson; R E Chance; N Moon
Journal:  Lancet       Date:  1976-05-22       Impact factor: 79.321

5.  Bovine pancreatic peptide: action on gastric and pancreatic secretion in dogs.

Authors:  T M Lin; D C Evans; R E Chance; G F Spray
Journal:  Am J Physiol       Date:  1977-03

6.  Mechanism of pancreatic polypeptide release in man.

Authors:  T E Adrian; H S Besterman; T J Cooke; S R Bloom; A J Barnes; R C Russell
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

  6 in total
  16 in total

1.  Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues.

Authors:  Veronika Mäde; Kathrin Bellmann-Sickert; Anette Kaiser; Jens Meiler; Annette G Beck-Sickinger
Journal:  ChemMedChem       Date:  2014-08-22       Impact factor: 3.466

Review 2.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 3.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

4.  Pancreatic polypeptide.

Authors:  T E Adrian
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

5.  Human pancreatic polypeptide in a phospholipid-based micellar formulation.

Authors:  Amrita Banerjee; Hayat Onyuksel
Journal:  Pharm Res       Date:  2012-03-08       Impact factor: 4.200

Review 6.  Regulation of appetite to treat obesity.

Authors:  Gilbert W Kim; Jieru E Lin; Michael A Valentino; Francheska Colon-Gonzalez; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

7.  Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.

Authors:  Michael A Valentino; Francheska Colon-Gonzalez; Jieru E Lin; Scott A Waldman
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

Review 8.  Antiobesity pharmacotherapy: new drugs and emerging targets.

Authors:  G W Kim; J E Lin; E S Blomain; S A Waldman
Journal:  Clin Pharmacol Ther       Date:  2013-10-08       Impact factor: 6.875

9.  High molecular weight PEGylation of human pancreatic polypeptide at position 22 improves stability and reduces food intake in mice.

Authors:  V Thieme; N Jolly; A N Madsen; K Bellmann-Sickert; T W Schwartz; B Holst; H M Cox; A G Beck-Sickinger
Journal:  Br J Pharmacol       Date:  2016-10-05       Impact factor: 8.739

Review 10.  Obesity pharmacotherapy: what is next?

Authors:  Francheska Colon-Gonzalez; Gilbert W Kim; Jieru E Lin; Michael A Valentino; Scott A Waldman
Journal:  Mol Aspects Med       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.